©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. May 24, 2025; 16(5): 101406
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.101406
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.101406
Can astragalus polysaccharides truly boost the treatment of pancreatic cancer?
Xiao-Bing Li, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, Hubei Province, China
Author contributions: Li XB analyzed, conceived, and wrote the manuscript.
Conflict-of-interest statement: The author declares that there are no conflicts of interest in this manuscript.
Corresponding author: Xiao-Bing Li, MD, PhD, Associate Professor, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 South Zhuodaoquan Road, Hongshan District, Wuhan 430079, Hubei Province, China. lixiaobing0629@126.com
Received: September 13, 2024
Revised: March 3, 2025
Accepted: March 11, 2025
Published online: May 24, 2025
Processing time: 248 Days and 20 Hours
Revised: March 3, 2025
Accepted: March 11, 2025
Published online: May 24, 2025
Processing time: 248 Days and 20 Hours
Core Tip
Core Tip: Astragalus polysaccharides combined with chemotherapy have demonstrated an enhanced efficacy and reduced toxicity in the treatment of pancreatic cancer. However, its true clinical value requires further research to be confirmed.